PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32679167-9	2020	Our results showed basal levels of GFAP, S100B, and pro-inflammatory cytokine increased in the epileptic rats but were significantly ameliorated after pretreatment with metformin.	Metformin	169-178	glial fibrillary acidic protein	Rattus norvegicus	35-39	
32779431-10	2020	Metformin decreased the expression of S100b, neuron specific enolase (Nse), and glial fibrillary acidic protein (Gfap).	Metformin	0-9	glial fibrillary acidic protein	Rattus norvegicus	80-111	
32779431-10	2020	Metformin decreased the expression of S100b, neuron specific enolase (Nse), and glial fibrillary acidic protein (Gfap).	Metformin	0-9	glial fibrillary acidic protein	Rattus norvegicus	113-117	
26606013-16	2015	The CCI-induced marked increase of GFAP immunoexpression has been reduced to moderate with fluoxetine (40) and pioglitazone, and to mild with metformin and the combination groups.	Metformin	142-151	glial fibrillary acidic protein	Rattus norvegicus	35-39	
30614910-5	2019	The number of neuronal nuclei positive neuron was significantly increased and glial fibrillary acidic protein positive astrocyte became obviously declined in the CA1 region in I/R rats treated with metformin.	Metformin	198-207	glial fibrillary acidic protein	Rattus norvegicus	78-109	
35386022-11	2022	In the metformin group, there was a reduction in cell apoptosis in the hippocampus, as well as GFAP-positive cells (P < 0.01).	Metformin	7-16	glial fibrillary acidic protein	Rattus norvegicus	95-99	
35103058-14	2022	GFAP level did not change in T2DM but rose in metformin and PA groups vs. control.	Metformin	46-55	glial fibrillary acidic protein	Rattus norvegicus	0-4	
35103058-15	2022	PA+metformin administration diminished GFAP vs. PA. T2DM-induced changes were associated with dramatically decreased ZO-1 levels, while PA treatment increased it almost to control values.	Metformin	3-12	glial fibrillary acidic protein	Rattus norvegicus	39-43